To provide exposure to companies that are involved in delivering sustainable products and services related to health and wellness globally. The Fund invests in equities of developed market companies that utilize technology and demonstrate innovation within the healthcare industry as well as companies that are enabling access to care, health, or wellness provision for a wide range of consumers including the elderly.

The Sub-Fund promotes environmental and/or social characteristics in accordance with Article 8 of the Sustainable Finance Disclosure Regulation (the “SFDR”).

In its implementation of the Fund’s ESG strategy, the Investment Manager tracks the Solactive Sustainable Health and Wellness Index-NR which is structured to represent the performance of companies that have high Environmental, Social and Governance (ESG) ratings relative to their sector peers, to ensure the inclusion of the best in-class companies from an ESG perspective.

The Fund’s environmental and/or social characteristics are assessed both quantitatively and qualitatively, by means of sustainability indicators as well as applying exclusions through the Fund’s replication of the Index as further described in the website disclosure’s dedicated sections. As part of its investment decision making process, the Fund’s ESG strategy also relies on the binding criteria used by the Index for the selection of underlying assets.

Finally, the Fund has a minimum allocation of 15% of its portfolio to sustainable investments. The Fund ensures that its sustainable investments do not cause significant harm to any environmental or social sustainable investment objective.

Please click here for more information.

Austria 
Denmark
Finland
France
Germany
Ireland
Italy
Luxembourg
Netherlands
Spain
Sweden
Switzerland
United Kingdom 

The Fund does not offer any capital guarantee or protection and you may not get back the amount invested.

The Fund is subject to the following risks which are materially relevant:
Concentration risk: the risk that arises when a fund invests in relatively few holdings, few sectors or a restricted geographic area. Performance may be more volatile than a fund with a greater number of securities.
Counterparty risk: the risk of failure of financial institutions or agents (when serving as a counterparty to financial contracts) to perform their obligations, whether due to insolvency, bankruptcy or other causes.
Derivative Instruments risk: the risk of loss in an instrument where a small change in the value of the underlying investment may have a larger impact on the value of such instrument. Derivatives may involve additional liquidity, credit and counterparty risks.
Foreign Currency risk: the risk of loss arising from exchange-rate fluctuations or due to exchange control regulations.
Index related risk: the risk that quantitative techniques used in creating the Index the Fund seeks to track do not generate the intended result, or that the portfolio of the Fund deviates from its Index composition or performance.
Secondary market trading risk: the risk that the shares purchased on the secondary market cannot usually be sold directly back to the Fund and that investors may therefore pay more than the NAV per share when buying shares or may receive less than the current NAV per Share when selling shares.

Complete information on the risks of investing in the Fund are set out in the Fund's prospectus.